Selection and evaluation of treatment regimens with direct-acting antiviral agents for patients with chronic hepatitis C in the real world in China
Chronic hepatitis C (CHC) is a chronic and progressive disease prevalent in the whole world and greatly threatens human health. The launch of direct-acting antiviral agents (DAAs) brings a revolutionary change in the treatment of CHC. In recent years, several DAAs have been marketed in foreign count...
Main Author: | AN Ziying |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2018-02-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8745 |
Similar Items
-
Real-World Results of Direct-Acting Antiviral Agents for Chronic Hepatitis C
by: Chun-Ming Hong, et al.
Published: (2018) -
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
by: Chun-Ming Hong, et al.
Published: (2020-08-01) -
Efficacy and safety of direct-acting antiviral agent regimens in a real-world cohort of adult Chinese patients with chronic hepatitis C virus infection
by: Jinyuan Wei, et al.
Published: (2020-06-01) -
Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus genotype 6 patients: Real-world experience in Vietnam.
by: Dung Thanh Nguyen, et al.
Published: (2020-01-01) -
Selection of direct-acting antiviral agents in treatment of chronic hepatitis C patients with renal dysfunction
by: CHEN Jianhong
Published: (2018-02-01)